Cellectar Biosciences Stock Market Value
| CLRB Stock | USD 0.25 0.01 4.17% |
| Symbol | Cellectar |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cellectar Biosciences. If investors know Cellectar will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cellectar Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Cellectar Biosciences is measured differently than its book value, which is the value of Cellectar that is recorded on the company's balance sheet. Investors also form their own opinion of Cellectar Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Cellectar Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cellectar Biosciences' market value can be influenced by many factors that don't directly affect Cellectar Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cellectar Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cellectar Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cellectar Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cellectar Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cellectar Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cellectar Biosciences.
| 11/02/2024 |
| 01/31/2025 |
If you would invest 0.00 in Cellectar Biosciences on November 2, 2024 and sell it all today you would earn a total of 0.00 from holding Cellectar Biosciences or generate 0.0% return on investment in Cellectar Biosciences over 90 days. Cellectar Biosciences is related to or competes with Monopar Therapeutics, Pulmatrix, Tenax Therapeutics, Bio Path, Capricor Therapeutics, NextCure, and Bolt Biotherapeutics. Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercial... More
Cellectar Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cellectar Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cellectar Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.20) | |||
| Maximum Drawdown | 77.99 | |||
| Value At Risk | (10.71) | |||
| Potential Upside | 8.33 |
Cellectar Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cellectar Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cellectar Biosciences' standard deviation. In reality, there are many statistical measures that can use Cellectar Biosciences historical prices to predict the future Cellectar Biosciences' volatility.| Risk Adjusted Performance | (0.15) | |||
| Jensen Alpha | (2.38) | |||
| Total Risk Alpha | (3.45) | |||
| Treynor Ratio | (1.25) |
Cellectar Biosciences Backtested Returns
Cellectar Biosciences secures Sharpe Ratio (or Efficiency) of -0.19, which signifies that the company had a -0.19 % return per unit of risk over the last 3 months. Cellectar Biosciences exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cellectar Biosciences' Standard Deviation of 11.45, risk adjusted performance of (0.15), and Mean Deviation of 5.52 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.77, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Cellectar Biosciences will likely underperform. At this point, Cellectar Biosciences has a negative expected return of -2.24%. Please make sure to confirm Cellectar Biosciences' total risk alpha, accumulation distribution, period momentum indicator, as well as the relationship between the potential upside and day median price , to decide if Cellectar Biosciences performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.24 |
Weak predictability
Cellectar Biosciences has weak predictability. Overlapping area represents the amount of predictability between Cellectar Biosciences time series from 2nd of November 2024 to 17th of December 2024 and 17th of December 2024 to 31st of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cellectar Biosciences price movement. The serial correlation of 0.24 indicates that over 24.0% of current Cellectar Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.24 | |
| Spearman Rank Test | 0.2 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Cellectar Biosciences lagged returns against current returns
Autocorrelation, which is Cellectar Biosciences stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Cellectar Biosciences' stock expected returns. We can calculate the autocorrelation of Cellectar Biosciences returns to help us make a trade decision. For example, suppose you find that Cellectar Biosciences has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Cellectar Biosciences regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Cellectar Biosciences stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Cellectar Biosciences stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Cellectar Biosciences stock over time.
Current vs Lagged Prices |
| Timeline |
Cellectar Biosciences Lagged Returns
When evaluating Cellectar Biosciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Cellectar Biosciences stock have on its future price. Cellectar Biosciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Cellectar Biosciences autocorrelation shows the relationship between Cellectar Biosciences stock current value and its past values and can show if there is a momentum factor associated with investing in Cellectar Biosciences.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Cellectar Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cellectar Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cellectar Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cellectar Biosciences Stock:Check out Cellectar Biosciences Correlation, Cellectar Biosciences Volatility and Cellectar Biosciences Alpha and Beta module to complement your research on Cellectar Biosciences. For information on how to trade Cellectar Stock refer to our How to Trade Cellectar Stock guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Cellectar Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.